Jeffrey A. Barnes

ORCID: 0000-0002-4867-1909

Also affiliated with Massachusetts General Hospital, Center for Cancer Research

Medicine

Pilot corpus only

This score is computed over theSindex pilot corpus and does not cover the full scientific literature. Scores are relative to papers we have ingested — papers, authors, and institutions outside the pilot are not represented. Methodology.

Top 100%percentile

0Author DataRank

Indexed papers

0in pilot corpus

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Papers

Driven by 2 papers. Top paper: “Short-duration infusion obinutuzumab with venetoclax in chronic lymphocytic leukemia: a prospective observational study”.

Short-duration infusion obinutuzumab with venetoclax in chronic lymphocytic leukemia: a prospective observational study

Blood Neoplasia(2025)10.1016/j.bneo.2025.100075

N/A

0DataRank · unranked

1 citations

Matthew Lei, Robert Redd, Ruchi Rana, Uvette Lou, Mark N Sorial +19 more

140 | PHASE 2 TRIAL OF LISOCABTAGENE MARALEUCEL (LISO‐CEL) IN COMBINATION WITH ACALABRUTINIB IN RELAPSED/REFRACTORY LARGE B‐CELL LYMPHOMAS (LBCL)

Hematological Oncology(2025)10.1002/hon.70093_140

N/A

0DataRank · unranked

0 citations

Jon Arnason, Robert Redd, J. Erika Haydu, Jacob D. Soumerai, Jeffrey A. Barnes +7 more